Mark Schrader

6.3k total citations
136 papers, 4.1k citations indexed

About

Mark Schrader is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mark Schrader has authored 136 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 57 papers in Pulmonary and Respiratory Medicine and 55 papers in Surgery. Recurrent topics in Mark Schrader's work include Prostate Cancer Treatment and Research (33 papers), Bladder and Urothelial Cancer Treatments (27 papers) and Prostate Cancer Diagnosis and Treatment (22 papers). Mark Schrader is often cited by papers focused on Prostate Cancer Treatment and Research (33 papers), Bladder and Urothelial Cancer Treatments (27 papers) and Prostate Cancer Diagnosis and Treatment (22 papers). Mark Schrader collaborates with scholars based in Germany, United States and Switzerland. Mark Schrader's co-authors include Kurt Miller, Hans Krause, Markus Müller, Andres Jan Schrader, Steffen Weikert, Frank Christoph, Michael Lein, Florian Jentzmik, Klaus Jung and Martin Schostak and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Mark Schrader

132 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Schrader Germany	33	1.9k	1.4k	1.0k	760	629	136	4.1k
Ihor S. Sawczuk United States	34	1.7k 0.9×	1.4k 1.0×	1.1k 1.1×	517 0.7×	1.0k 1.6×	108	4.1k
Giovanni Luca Gravina Italy	44	2.2k 1.2×	1.2k 0.8×	475 0.5×	783 1.0×	1.3k 2.0×	187	5.2k
Hiroaki Shiina Japan	42	2.5k 1.3×	1.2k 0.8×	1.1k 1.1×	605 0.8×	720 1.1×	198	4.6k
Gaetano Facchini Italy	32	1.1k 0.6×	1.2k 0.9×	685 0.7×	684 0.9×	1.2k 1.9×	189	3.4k
Jie Cai China	35	813 0.4×	696 0.5×	1.4k 1.4×	386 0.5×	1.2k 1.9×	163	3.8k
Kouji Izumi Japan	29	888 0.5×	1.4k 1.0×	430 0.4×	454 0.6×	985 1.6×	219	3.4k
Xu Zhang China	38	2.8k 1.5×	1.4k 1.0×	952 0.9×	1.8k 2.4×	972 1.5×	285	5.4k
Tanya B. Dorff United States	36	1.4k 0.7×	1.9k 1.4×	879 0.9×	820 1.1×	1.6k 2.5×	288	5.2k
Matteo Puntoni Italy	33	1.7k 0.9×	658 0.5×	731 0.7×	1.2k 1.6×	1.8k 2.9×	139	4.8k
Haojie Li China	27	1.0k 0.5×	1.1k 0.8×	684 0.7×	675 0.9×	912 1.4×	137	3.8k

Countries citing papers authored by Mark Schrader

Since Specialization

Citations

This map shows the geographic impact of Mark Schrader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Schrader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Schrader more than expected).

Fields of papers citing papers by Mark Schrader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Schrader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Schrader. The network helps show where Mark Schrader may publish in the future.

Co-authorship network of co-authors of Mark Schrader

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Schrader. A scholar is included among the top collaborators of Mark Schrader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Schrader. Mark Schrader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keller, Jan, Silke Burkert, Amelie U. Wiedemann, et al.. (2015). Individual and dyadic planning predicting pelvic floor exercise among prostate cancer survivors.. Rehabilitation Psychology. 60(3). 222–231. 10 indexed citations

Roos, Frederik C., Sandra Steffens, Kerstin Junker, et al.. (2014). Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma. BMC Cancer. 14(1). 372–372. 26 indexed citations

Magheli, Ahmed, Jonas Busch, Mark Schrader, et al.. (2014). Comparison of surgical technique (Open vs. Laparoscopic) on pathological and long term functional outcomes following radical prostatectomy. BMC Urology. 14(1). 18–18. 18 indexed citations

Luedeke, Manuel, Friedemann Zengerling, Felicitas Genze, et al.. (2014). Stilbene Induced Inhibition of Androgen Receptor Dimerization: Implications for AR and ARΔLBD-Signalling in Human Prostate Cancer Cells. PLoS ONE. 9(6). e98566–e98566. 23 indexed citations

Knoll, Nina, Amelie U. Wiedemann, Martin Schultze, Mark Schrader, & Jutta Heckhausen. (2014). Prostate cancer patients gradually advance goals for rehabilitation after radical prostatectomy: Applying a lines-of-defense model to rehabilitation.. Psychology and Aging. 29(4). 787–792. 12 indexed citations

Steffens, Sandra, Martin Janssen, Frederik C. Roos, et al.. (2014). The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma. Human Pathology. 45(12). 2411–2416. 11 indexed citations

Baumunk, D., Carsten Kempkensteffen, Ursula Steiner, et al.. (2013). Interdisciplinary decision making in prostate cancer therapy – 5-years’ time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin. BMC Medical Informatics and Decision Making. 13(1). 83–83. 7 indexed citations

Steinestel, Julie, Marcus V. Cronauer, Johannes Müller, et al.. (2013). Overexpression of p16INK4a in Urothelial Carcinoma In Situ Is a Marker for MAPK-Mediated Epithelial-Mesenchymal Transition but Is Not Related to Human Papillomavirus Infection. PLoS ONE. 8(5). e65189–e65189. 35 indexed citations

Luedeke, Manuel, Natalia Bogdanova, Antje E. Rinckleb, et al.. (2012). Prostate Cancer Risk Is not Altered by TP53AIP1 Germline Mutations in a German Case-Control Series. PLoS ONE. 7(3). e34128–e34128. 6 indexed citations

10.

Spindler, Klaus‐Dieter, et al.. (2012). JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells. BMC Cancer. 12(1). 130–130. 41 indexed citations

11.

Jentzmik, Florian, Andres Jan Schrader, R. de Petriconi, et al.. (2012). The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome. World Journal of Urology. 30(6). 733–739. 35 indexed citations

12.

Wenz, Frederik, Thomas J. Martin, Dirk Böhmer, et al.. (2010). The German S3 Guideline Prostate Cancer. Strahlentherapie und Onkologie. 186(10). 531–534. 16 indexed citations

13.

Jentzmik, Florian, Carsten Stephan, Kurt Miller, et al.. (2010). Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. European Urology. 58(1). 12–18. 192 indexed citations

14.

Thilo, Florian, D. Baumunk, Hans Krause, et al.. (2009). Transient receptor potential canonical type 3 channels and blood pressure in humans. Journal of Hypertension. 27(6). 1217–1223. 20 indexed citations

15.

Kempkensteffen, Carsten, Steffen Weikert, Stefan Hinz, et al.. (2007). The equilibrium of XIAP and Smac/DIABLO expression is gradually deranged during the development and progression of testicular germ cell tumours. International Journal of Andrology. 30(5). 476–483. 20 indexed citations

16.

Kempkensteffen, Carsten, Frank Christoph, Steffen Weikert, et al.. (2006). Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors. Journal of Cancer Research and Clinical Oncology. 132(12). 765–770. 15 indexed citations

17.

Kempkensteffen, Carsten, Stefan Hinz, Frank Christoph, et al.. (2006). Expression parameters of the inhibitors of apoptosis cIAP1 and cIAP2 in renal cell carcinomas and their prognostic relevance. International Journal of Cancer. 120(5). 1081–1086. 27 indexed citations

18.

Weikert, Steffen, Hans Krause, Ingmar Wolff, et al.. (2005). Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer. International Journal of Cancer. 117(2). 274–280. 30 indexed citations

19.

Schrader, Mark, Stuart E. Ravnik, Carsten Müller‐Tidow, et al.. (2002). Quantification of cyclin A1 and glyceraldehyde‐3‐phosphate dehydrogenase expression in testicular biopsies of infertile patients by fluorescence real‐time RT‐PCR. International Journal of Andrology. 25(4). 202–209. 4 indexed citations

20.

Schrader, Mark, Angelika M. Burger, Markus Müller, et al.. (2002). The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase. BMC Cancer. 2(1). 32–32. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact